Calcium and calmodulin (CaM) are known t o play critical roles in controlling cell cycle progression in a variety of cells. We observed that the CaM antagonist, N-(6-aminohexyl)-Bchloro-1-naphthalensulfonamide hydrochloride (W-71, inhibited 'H-thymidine incorporation into DNA of factor-dependent hematopoietic cells. To delineate the role of CaM in proliferation of hematopoietic cells, we have investigated intracellular distribution of specific CaM-binding proteins (CaM-BPs) in response t o hematopoietic growth factors in FDC-P1.32D. NFS-60, and T1165 cells. Each of these cell lines, when deprived of cytokines for 16 t o 18 hours, essentially ceased proliferation, even in the presence of fetal calf serum. Concomitant t o the cessation of proliferation, there was a dramatic depletion of a specific CaM-BP of about 68 Kd in both their cytoplasmic and nuclear fractions. Within 6 t o 12 hours of reexposure t o proliferation-specific cytokines, there ROLIFERATION of eukaryotic cells is controlled by a P series of regulatory events, including expression and intracellular redistribution of enzymes and other proteins associated with DNA synthesis, occurring during G1 phase of the cell cycle.'s2 Although it is well known that growth factors or cytokines are required to stimulate the proliferation of hematopoietic cells,3-' very little is known about the regulatory process(es) stemming from growth factor/ receptor interactions on the membrane that culminates in the induction of nuclear DNA replication and cellular proliferation.
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Interaction between growth factors and their receptors are commonly associated with the activation of phospholipase C that leads to the formation of diacylglycerol (DG) and inositol 1,4,5, triphosphate (IP,) from phosphatidylinosito1 4,5-bisphosphate (PIP,). DG is known to activate and redistribute phosphatidyl serine-dependent protein kinase C,8-11 which phosphorylates serine and/or threonine residues of its target proteins, including adenylate cyclase.12 IP, is known to cause the release of Ca2+ from intracellular leading to the activation of calmodulin (CaM). Activated CaM is reported to regulate cyclic nucleotides by was a restoration of the nuclear as well as cytoplasmic 68-Kd CaM-BP. Furthermore, such an induction and nuclear localization of the 68-Kd CaM-BP by the cytokines coincided temporally with the progression of synchronized FDC-PI cells from G1 t o S phase. By contrast, colony-stimulating factor-1 (CSF-1)-dependent bone marrow macrophages and BAC-1 cells did not exhibit 68-Kd CaM-BP in the nuclear or cytoplasmic fractions. These studies suggest that while hematopoietic growth factor granulocyte CSF-, granulocyte-macrophage CSF-, interleukin-3 (lL-3)-, or IL-6-, whose receptors are members of the hematopoietin receptor family, induced cell proliferation is associated with a common mechanism involving nuclear localization of the 68-Kd CaM-BP, the CSF-1-induced proliferation seems t o involve 68-Kd CaM-BPindependent pathways. o 1992 by The American Society of Hematology.
activating phosphodiesterase" and cyclase^,'^^'^ and protein phosphorylation through activation of CaM-dependent protein kinases18,'y and phosphatases.20az1 While the activation of protein kinases and generation of cyclic nucleotides (CAMP and cGMP) after PIP, turnover have been implicated in hematopoietic reg~lation,"'*~~-~~ their causal relation to, or the specific mechanism of action in, the growth factor-dependent transition of cells from G1 to S phase remains obscure.
In serving as a Ca2' receptor protein, CaM appears to be critically involved in the regulation of mammalian cell proliferation, particularly at the G1 /S bo~ndary.*~-~' CaM has also been implicated in factor-dependent proliferation of human hematopoietic progenitor cells.28 Proliferative stimulation of rat liver cells is observed to be accompanied by the nuclear rearrangement of CaM by its association with the nuclear matri~.~'.~' Specific CaM-binding proteins (CaM-BPs) are found to be associated with DNA polymerase-cx from a variety of mammalian cells3' and with the multienzyme complex responsible for nuclear DNA replication in fibroblast cells.32 In addition, the nuclear localization of the 68-Kd CaM-BP in Chinese hamster fibroblast cells is dependent on the induction of cell proliferation in these cells by exposure to insulin.32 These observations suggest that the induction and/or nuclear localization of specific CaM-BP(s) may control a terminal event required for the onset of DNA replication and, therefore, for cell proliferation. To evaluate this possibility, we examined the changes in intracellular levels and organization of CaM-BPs that could be directly attributed to the proliferative stimulation of hemolymphopoietic progenitor cells by cytokines. In our analysis with interleukin-3 (IL-3)-, IL-6, granulocytemacrophage colony-stimulating factor (GM-CSF)-, or granulocyte CSF (G-CSF)-responsive cell lines, we observed that the stability of the 68-Kd CaM-BP, as determined by its ability to bind to CaM, and its nuclear localization were dependent on the exposure of hematopoietic cells to the cytokines with proliferative potential and that the nuclear North Carolina Tissue Culture Bank (NCTC; from MA Bioproducts, Baltimore, MD), 2 mmol/L glutamine, and 20% h e l l cm (a source of CSF-1). All these culture media contained 100 U/mL penicillin and 100 p,g/mL streptomycin and the cultures were maintained at 37°C in humidified 5% CO, containing incubators. BMM were purified from BM cells obtained from the femora and tibia of mice according to the procedure of Gilbert and Stanley?' Purified BMM were then grown in DMEM (GIBCO) supplemented with 15% FCS, 0.02 mg/mL L-asparagine, 50 pmol/L mercaptoethanol, 100 U/mL penicillin, 100 pg/mL streptomycin, and 5% adherent stromal cell line TC-1 cm (a source of CSF-1) at 37°C in a humidified incubator containing 10% CO,.
Measurement of 'H-thymidine incovomtion into DNA of FDC-PI cells. FDC-P1 cells were grown to a density of about 1 x 106 cells/mL in 24-well tissue culture plates. Exponentially growing 1 mL individual cultures were then treated with varying concentrations of CaM antagonist, N-(6-aminohexyl)-5-chloro-l-naphthalesulfonamide hydrochloride (W-7), or the chlorine-deficient analogue of W-7, N-(6-aminohexyl)-l-naphthalenesulfona1ride hydrochloride (W-5) (both W-7 and W-5 were purchased from Seikagaku Kogyo Co, Tokyo, Japan). Control cultures received equal amounts of phosphate-buffered saline (PBS), which was used for diluting the drugs W-7 and W-5. Fifteen minutes after the drug treatment, cells were incubated with 5 pCi/mL of 'H-thymidine (purchased from ICN Biomedicals, Inc, Costa Mesa, CA) for 60 minutes. Incorporation of 'H-thymidine into acid-precipitable material was terminated by adding trichloroacetic acid (TCA) to a final concentration of 10% to each culture. Cultures were incubated on ice for 15 minutes and the precipitate formed was recovered by centrifugation at 10, OOO rpm for 10 minutes in a Sorvall RC-5B centrifuge (DuPont Co, Wilmington, DE) using a SM-24 rotor. Precipitate was dissolved in 0.5 mL of 0.4 mol/L NaOH and reprecipitated by adding TCA to a final concentration of 10% and incubating on ice for 15 minutes. Each sample was diluted five-fold with ice-cold H,O and the precipitate was once again recovered by centrifugation. Precipitate was then dissolved in 0.5 mL of 0.4 mol/L NaOH, and 0.1 mL aliquots were counted for radioactivity in 5 mL "Ready Protein" scintillation cocktail (Beckman, Fullerton, CA).
Cells grown in suspension or after trypsinization of those grown in monolayers were collected by centrifugation and washed once with buffer A (35 mmol/L HEPES [7.4] to 40 pulses. The nuclear homogenate was then cleared by centrifugation at 5,OOO rpm and 4°C for 10 minutes in an RC-SB Sorvall centrifuge equipped with a SS-34 rotor, and the supematant was used as the nuclear fraction.
Logarithmically growing FDC-PI cells adapted to grow in DMEM supplemented with 10% FCS, 25% WEHI-3 cm, 100 U/mL penicillin, 100 &mL streptomycin were washed once in isoleucine-deficient DMEM and suspended in isoleucine-deficient DMEM containing 10% dialyzed FCS (purchased from Sigma Chemical CQ, St Louis, MO), 25% dialyzed WEHI-3 cm (dialyzed against PBS), 100 U/mL penicillin, and 100 pg/mL streptomycin, and incubated at 37°C in a humidified incubator with 5% CO, for 32 to 36 hours. These cells were then harvested by centrifugation and suspended in complete medium containing 10% FCS and 25% WEHI-3 cm or IG3 (100 U/mL) in place of WEHI-3 cm. Synchronous progression of cells from G1 to S phase was then monitored by examining 'H-thymidine incorporation into DNA at regular intervals after releasing from isoleucine block, as described above.
Deprivation and readdirion of hematopoietic growth factors to cells. Cells were deprived of growth factors by harvesting and washing them once in medium containing FCS but no cm or cytokines. Cells were then incubated in cytokine-free medium containing 10% FCS for 16 to 18 hours. These cells essentially stop proliferating, as determined by 'H-thymidine uptake and cell count measurements (data not shown). Specific cytokines or the cm-containing cytokines were then added back at appropriate concentrations and incubated for 6 to 12 hours. At 12 hours after the addition of cytokines, cells begin to incorporate 'H-thymidine into their DNA.
Unless otherwise noted, 40 to 50 pg of protein samples of either cytoplasmic or nuclear fractions was subjected to polyacrylamide gel electrophoresis under denaturing conditions as described by Laemmli" using a mini-gel apparatus (BioRad, Richmond, CA). Proteins resolved on 10% polyacrylamide gels were then transferred to nitrocellulose filters at 200 mA for 1 to 2 hours in a Hoefer Scientific "transphor electrophoresis" unit. CaM-BPs on the filters were identified by using biotinylatedCaM (purchased from Biomedical Technologies, Inc, Stoughton, MA) and alkaline phosphatase-conjugated avidin (purchased from Boehringer Mannheim Biochemicals, Indianapolis, IN), as described by Billingsley et al." The binding specificity of CaM to the proteins transferred to nitrocellulose filters in this assay was determined by the requirement of Ca2+ in the assay reaction mixtures,12 and by its sensitivity to CaM antigonist W-7 (data not shown), as described by Billingsley et al." Prestained molecular weight markers (purchased from Bethesda Research Laboratories, Bethesda, MD) were used to identify the relative molecular weights of CaM-BPs detected on the filters.
FDC-P1 cell lysates prepared at regular intervals after releasing from isoleucine block were assayed for thymidine kinase activity essentially as described elsewhere?, Protein content in individual fractions was determined by the method of Lowry et
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RESULTS
Effect of W-7 and W-5 on 'H-thymidine incorporation into DNA of FDC-PI cells.
We observed that the factordependent proliferation of myeloid FDC-P1 cells is inhibited by W-7, a CaM antagonist," as determined by 'Hthymidine incorporation into DNA (Fig 1) . The effect of W-7 is consistent with the inactivation of CaM, because the chlorine deficient analogue of W-7, W-5, a weaker antagonist for CaM," is less effective in causing similar effects (Fig  1) . This observation is consistent with the report that IL-3-, GM-CSF-, or G-CSF-stimulated colony formation of myeloid progenitor cells is sensitive to CaM antagonists% and, therefore, CaM may play a role in proliferation of myeloid 
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cells. To evaluate further the causal relationship between
CaM inactivation and prevention of cell proliferation, we examined intracellular distribution of specific CaM-BPs in response to proliferation-associated cytokines in FDC-Pl cells. When FDC-Pl cells were deprived of growth factors, stopped growing (data not shown), and concomitantly there was a significant decrease in a specific CaM-BP of about 68 Kd, as determined by its ability to bind to CaM, in the whole cell lysate (Fig 2) . Such a decrease was mOre evident in the cytoplasmic and nuc1ear fractions Of the ce11s deprived Of WEHI-3 cm (Fig 2) . In whole Cell lysates, as compared with cytoplasmic and nuclear fractions, relatively more protein represented membrane and other cellular components. The decrease of the 68-Kd CaM-BP in the absence of ~~1 -3 cm is intriguing, particularly when one considers that this decrease was independent of the factors in the FCS to which the cells were constantly exposed even during WEHI-3 cm deprivation. Furthermore, when the cells were reexposed to WEHI-3 cm, there was an a h " complete restoration of 68-Kd CaM-BP levels in the whole cell lysate, and a corresponding increase in both the cytoplasmic and bY e1iminating WEH13 cm in the culture mediumv they
washing twice with WEHI-3 cm-deficient medium, and incubating the the nuclear fractions, reaching levels observed with exponentially growing cultures (Fig 2) , and the cells subsequently began to proliferate (data not shown).
Effect of spec@c growth factors on the restoration of the 68-Kd CaM-BP in the cells deprived of growth factors. Restoration of 68-Kd CaM-BP levels by WEHI-3 cm in FDC-pl cells is probably due to the presence of &3 because this is the major cytokine present in ~~1 -3 cm to which FDC-Pl cells respond with proliferation. This was further explored by refeeding WEHI-3 cm-deprived cells with IL-3 or GM-CSF in place of WEHI-3 cm. As shown in Fig 3A, these cytokines, individually, could substitute for WEHI-3 cm in restoring 68-Kd CaM-BP in the nuclear fraction of FDC-PI cells. Thus, from these observations it seems that the restoration of the 68-Kd CaM-BP may occur, particularly in response to cytokines with proliferative potential for specific factor-dependent hemolymphopoietic cells. This concept is supported by examining 32D, NFS-60, and T1165 cells. When 32D cells were growth factor deprived there was a decrease in the nuclear 68-Kd CaM-BP (Fig 3A) , which could be reversed only in the presence of IL-3 (which supports the proliferation of 32D cells) but not in the presence of GM-CSF (which does not support the growth of 32D cells). Actually, in the presence of GM-CSF, the nuclear 68-Kd CaM-BP continued to decrease with time ( Fig 3A) . Similar changes in the nuclear 68-Kd CaM-BP were seen in NFS-60 cells when deprived for WEHI-3 cm and when reexposed to specific growth factors (IL-3 and G-CSF) that induce their proliferation (Fig 3B) . factor-deprived T1165 cells. Log-growing cells were deprived of growth factors in conditioned medium for 16 hours as described in Materials and Methods and the growth factor-deprived FDC-PI. 32D. and NFS-60 cells were then refed with mlL-3 (100 U/mL; GIBCO), mGM-CSF (65 U/mL; Biogen), or hG-CSF (20,000 U/ mL; Amgen) as indicated for 6 or 12 hours. Growth factor-deprived T1165 cells were refed with IL-6 containing COS cell conditioned medium for 12 hours. The cells, before deprivation (log-growing), after deprivation for 16 hours (deprived) and readdition of growth factors, were harvested by centrifugation and the cytoplasmic and nuclear lysates were prepared, and CaM-BPs in individual fractions were analyzed as described in Material and Methods. Prestained molecular weight markers (Bethesda Research Laboratories) were used t o identify the relative molecular weights of CaM-BPs on the filters.
IL-6-dependent T116 cells also exhibited changes in cytoplasmic as well as the nuclear 68-Kd CaM-BP in response to growth factor deprivation and readdition (Fig 3C) . From these studies it is evident that the nuclear association and stability of the 68-Kd CaM-BP in hematopoeitic cells is highly dependent on the exposure of the cells to growth factors acting through the hematopoietin receptor family. In our investigations testing the universality of the relationship between growth factor-induced proliferation and the modulation of the 68-Kd CaM-BP in hematopoietic cells, we examined CSF-l-dependent BMMs and BAC-1 cells. In contrast to IL-3-, IL-6-, G-CSF-, or GM-CSFdependent hematopoietic cells, 68-Kd CaM-BP could not be detected in cytoplasmic or nuclear fractions of BMMs (Fig 4A) or in BAC-1 cells (Fig 4B) . Thus, CSF-1-induced proliferation may involve 68-Kd CaM-BP-independent pathways (see Discussion).
To understand the significance of the nuclear and cytoplasmic localization of the 68-Kd CaM-BP in growth factor-dependent proliferation of hematopoietic cells, we have developed a cell synchronization method in which the relationship between the growth factor-dependent intracellular distribution of the 68-Kd CaM-BP and the induction of S phase could be evaluated. As shown in Fig 5A, FDC-PI cells synchronized by the isoleucine starvation method could progress from G1 to S phase only in the presence of WEHI-3 cm or IL-3. However, in the absence of the growth factors (ie, WEHI-3 cm or IL-3), but in the presence of medium with 10% fetal bovine serum alone, cells did not progress through the cell cycle from G1 to S phase (Fig 5A) , even though more than 90% of the cells were viable at all times, as determined by Trypan Blue exclusion (data not shown). Additional evidence for the synchronous progression of FDC-P1 cells from G1 to S phase in the presence of IL-3 or WEHI-3 cm, but not in their absence, is provided by the expression of thymidine kinase activity (Fig 5B) , a late-G1 marker." Intracellular dktnbution of CaM-BPs as FDC-PI cells progress synchronously from GI to S phase. An analysis of the CaM-BPs at regular intervals as cells progressed synchronously from G1 to S showed that the induction and the nuclear localization of the 68-Kd CaM-BP is associated preferentially with the ability of cells to progress from G1 to S phase in response to growth factors. In FDC-P1 cells released from 32-hour isoleucine starvation, the level of cytoplasmic 68-Kd CaM-BP apparently remained unchanged in the absence of WEHI-3 cm, and increased twofold to threefold in the presence of WEHI-3 cm ( Fig  6A) during a 12-hour period. Under the same conditions, nuclear 68-Kd CaM-BP actually decreased significantly in the absence of WEHI-3 cm and exhibited a proportionate increase, corresponding to the ability of cells to progress from G1 to S phase, in the presence of WEHI-3 cm ( Fig  6B) . A dramatic difference in nuclear 68-Kd CaM-BP in the presence and the absence of WEHI-3 cm, particularly at the time (8 to 10 hours after releasing from isoleucine block) when the cells are scheduled to progress from G1 to S phase (Fig 5A) , is evident from the densitometric analysis of the 68-Kd CaM-BP band on original filters (Fig 6C) . A similar densitometric analysis of the other two CaM-BPs (of about 75 and 120 Kd) did not exhibit any significant changes after the release from isoleucine block that corresponded with the ability of cells to progress from G1 to S phase (data not shown). The changes observed in cytoplasmic and nuclear 68-Kd CaM-BP, after the release from isoleucine block, reflect the role of growth factors in restoring 68-Kd CaM-BP to a threshold level critical for the progression of cells from G1 to S phase. This is further substantiated from our observation that, when smaller quantities of protein (20 pg, instead of 50 pg, per lane) were analyzed on the filters, the 68-Kd CaM-BP was hardly visible in the nuclear fraction at any time in the absence of the growth factors (Fig 6D) , and the cells failed to progress into S phase (Fig 5A) . However, in the presence of IL-3 alone, or in the presence of WEHI-3 cm, the nuclear 68-Kd CaM-BP was detected at the time when cells begin to progress from G1 to S phase (Fig 6D) . These observations show that the growth factor-dependent increase in cytoplasmic and nuclear 68-Kd CaM-BP in hematopoietic cells is associated preferentially with their progression from G1 to S phase.
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DISCUSSION
The present data indicate that the growth factordependent induction and nuclear localization of the 68-Kd CaM-BP are associated with the transition of hematopoietic cells from G1 to S phase. We have shown that the stability, as determined by CaM-binding assay, and the nuclear localization of the 68-Kd CaM-BP is highly dependent on, and seems to be unique to, the growth factors with proliferation potential. Furthermore, the nuclear localization of this protein is temporally related to the ability of FDC-P1 cells to progress from G1 to S phase in synchronized cultures.
Hemolymphopoietic cell proliferation is highly sensitive to CaM antagonists,= and is dependent on the availability of Ca+* in culture medium?941 Accordingly, we observed that 3H-thymidine incorporation into DNA of FDC-P1 cells is inhibited by the inactivation of intracellular CaM (Fig 1) . CaM is shown to be critically involved in proliferation of a variety of mammalian cells, particularly at the G l / S boundary.25-27242 CaM levels are elevated twofold to threefold during late G1 period, and a direct correlation was observed between intracellular CaM levels and the ability of mammalian cells to replicate DNA.43 Furthermore, the stimulatory effect of Ca+2 on DNA synthesis is blocked by CaM antagonists, or antibody.* While these observations point to a pivotal role of CaM in cellular proliferation, its mechanism of action in inducing cell growth remains obscure.
In the present studies, we have identified a protein of about 68 Kd that binds specifically to CaM, and whose cytoplasmic and nuclear detection by CaM-binding assay was dependent on the exposure of hematopoietic cells to growth factors. Among several CaM-BPs in cytoplasmic and nuclear fractions of hematopoietic cells identified by the CaM-binding assay used in the present studies, we observed that a 68-Kd protein is the only CaM-BP that exhibited a consistent and reproducible changes in response to the availability of growth factors in the culture medium. The growth factors, preferentially those with a potential to induce cellular proliferation, are involved in induction and nuclear localization of the 68-Kd CaM-BP, as exemplified by the observations that IL-3, but not GM-CSF, is capable of restoring the 68-Kd CaM-BP in 32D cells deprived of growth factors (Fig 3A) . In the presence of GM-CSF, which does not promote the proliferation of 32D cells, there was a continued depletion of the 68-Kd CaM-BP both in the nuclear (Fig 3A) , as well as cytoplasmic (data not shown) fractions. IL-3 and GM-CSF in FDC-P1 cells, IL-3 and G-CSF in NFS-60 cells, and IL-6 in T1165 cells were able to restore 68-Kd CaM-BP in growth factordeprived cells in accordance with their abilities to induce cellular proliferation.
In a sharp contrast to the observations made with IL-3-, GM-CSF-, G-CSF-, and IL-&dependent hematopoietic cells, CSF-l-dependent cells exhibited complete absence of the 68-Kd CaM-BP in their cytoplasmic and nuclear fractions. This is verified by examining two different cell systems, viz, BMMs and BAC-1 cells (Fig 4A and B) . However, it is not clear from our observations whether minor changes observed in other CaM-BPs, after deprivation or readdition of CSF-1, could have any significance in regulating proliferation of CSF-1-dependent cells. An absence of 68-Kd CaM-BP in CSF-1-dependent cells is intriguing, particularly in the light of structural differences between CSF-1 receptor, a c-fms proto-oncogene produ~t,4~ and the hematopoietin receptor family.46 48 Furthermore, Hours after releasing from isoleucine block while the CSF-1 receptor is a tyrosine kinase?* GM-CSF, G-CSF, IL-3, and IL-6 receptors have no known kinase activity. Because CSF-1 and PDGF receptors are grouped as tyrosine kinase receptors with structural similarities,"." it is possible that, like PDGF," CSF-1 in hematopoietic cells could serve as a progression factor during early stages of G1 period. On the other hand, GM-CSF, G-CSF, IL-3, and IL-6 may serve as competence factors, as has been described for ~omatomedins?'~~~ Such a possibility was also raised from studies with IL-3 in C-63 cell:' Thus, it is possible that 68-Kd CaM-BP4ependent pathways in growth factor action may be unique to those that serve as competence factors. This is consistent with our earlier observation that the nuclear localization of the 68-Kd CaM-BP is associated with insulin-mediated onset of DNA replication in fibroblast cells.'* The changes in intracellular protein(s) that are critical to the progression of cells from G1 to S phase after growth factor-receptor interaction are often indistinguishable from those that are occurring as a consequence of returning of the cells from a growth arrested state. By using a cell synchronization method involving isoleucine starvation to arrest the cells in early G1 phase, and then monitoring the ability of cells to progress into S phase in response to growth factors, we were able to distinguish changes in 68-Kd CaM-BP that are unique to growth factor-dependent progression of FDC-P1 cells from G1 to S phase (Fig 6) . In synchronized FDC-P1 cells, we observed a temporal relationship between the detection of 68-Kd CaM-BP in nuclear fraction and the 3H-thymidine incorporation into DNA. In addition, the 68-Kd CaM-BP could not be detected in nuclear fraction of the cells that were released from isoleucine block but were subsequently deprived for growth factors (Fig 6C) . These observations clearly show that the nuclear localization of the 68-Kd CaM-BP is intrinsic to the proliferative stimulation of hematopoietic cells by growth factors.
Our identification of 68-Kd CaM-BP as a mediator of CaM action in cellular proliferation is consistent with the mechanisms by which CaM is known to regulate other metabolic processes. CaM, a ubiquitous protein, is known to control several metabolic processes in mammalian cells by its binding to specific regulatory proteins/enzyme~?~~~~ Similarly, Ca+2/CaM, as second messengers in the action of growth factors, may regulate DNA synthesis by binding to the protein(s) associated with the enzymes of DNA replication. In this regard, it is interesting to note that specific CaM-BPs are tightly associated with purified DNA polymerase-a from a variety of mammalian cells." It is also observed that the 68-Kd CaM-BP is associated with the multienzyme complex, called replitase, responsible for nuclear DNA replication in mammalian cells.'2 A temporal interaction of the 68-Kd CaM-BP with the enzymes of DNA replication, as predicted from its detection in the nuclear fraction of synchronized FDC-P1 cells (Fig 6C) , during the cell cycle may possibly govern the assembly and/or structural stability of the replitase complex that determines the catalytic activity of DNA-synthesizing enzymes.s637
There are many proteins with 68 Kd molecular weight that are known to be regulated in response to proliferative stimulation. These proteins include Na+/H' antip0rter,5"~* p68 nuclear protein from HeLa cells? human p68 protein with RNA helicase activity,@' and cell cycle restriction protein:' While each of these proteins has potential to serve a regulatory role in the control of cellular proliferation, it is not known whether any of them also bind to CaM, to account for the 68-Kd CaM-BP identified in the present studies.
Altogether, our observations indicate that GM-CSF-, G-CSF-, IL-3-, and IL-6-dependent proliferative stimulation is associated with the modulation of a specific 68-Kd CaM-BP in myeloid progenitor cells. Furthermore, from earlier observations with insulin in fibroblast cellsg2 and from the present studies with four different factordependent myeloid cells, it seems that the onset of DNA replication by growth factors at G1 /S boundary are being controlled by a common mechanism involving nuclear localization of the 68-Kd CaM-BP in a variety of mammalian cells. Such a role for the 68-Kd CaM-BP may also be attributed to a stringent requirement of Ca+' for the proliferation of hemolymphopoietic cells.
